TORONTO (AP) — TORONTO (AP) — Intellipharmaceutics International Inc. (IPCIF) on Friday reported a loss of $54,000 in its fiscal second quarter.
The Toronto-based company said it had a loss of less than 1 cent on a per-share basis.
The extended-release drug developer posted revenue of $480,200 in the period. Its adjusted revenue was $480,000.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a IPCIF">Zacks stock report on IPCIF at https://www.zacks.com/ap/IPCIF